Faruqi and Faruqui, LLP Logo
Share this page

Bio-Rad Laboratories, Inc. (BIO)



Faruqi & Faruqi, LLP is Investigating Bio-Rad Laboratories, Inc. (BIO) on Behalf of its Shareholders

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Bio-Rad Laboratories, Inc. (“Bio-Rad” or the “Company”) (NYSE: BIO).

The investigation focuses on whether the Company and its officers breached their fiduciary duties by causing or allowing Bio-Rad to engage in corrupt and illegal practices, particularly in connection with the Company’s business in Russia and Southeast Asia.

On November 3, 2014, Bio-Rad announced the resolution of investigations conducted by the U.S. Department of Justice (“DOJ”) and Securities and Exchange Commission (“SEC”) into the Company’s violations of the Foreign Corrupt Practices Act (“FCPA”) between the years 2005 and 2010 in Russia, Vietnam and Thailand.

Although the DOJ declined to prosecute Bio-Rad, the parties entered into a Non-Prosecution Agreement through which Bio-Rad will be charged a total of roughly $55 million. The Company is also required to implement more stringent compliance and reporting measures over the next two years.

Take Action

If you currently own Bio-Rad stock and have continuously owned Bio-Rad stock since at least January 1, 2005, and would like to discuss your legal rights, please contact us by calling Stuart Guber toll free at (215) 277-5770 or by sending an e-mail to sguber@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Bio-Rad’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information on how to join the Action.

  • Company:
    Bio-Rad Laboratories, Inc. (BIO)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Stuart J. Guber
Faruqi & Faruqi, LLP
1617 JFK Boulevard, Suite 1550
Philadelphia, PA 19103
Tel: (215) 277-5770


Case Details


  • 11/04/2014

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.